[Assessment of efficacy of thrombolytic therapy in the treatment and prognosis of myocardial infarction].
An apparent benefit has been shown to occur in acute myocardial infarction from the thrombolytic and antiaggregation therapy, that was evidenced by the absence of early post-infarction angina pectoris, decline in the incidence of disturbances of the heart's rhythm and conductivity, shortening of the hospital stay.
Soleĭko
L P
LP
Bashinskaia
V P
VP
Soleĭko
E V
EV
Balabaeva
N A
NA
Ganskaia
L I
LI
Psiuk
V I
VI
Maslovskiĭ
V Iu
VIu
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011379:Prognosis; D015912:Thrombolytic Therapy / Q000009:adverse effects
D010975:Platelet Aggregation Inhibitors